NEW YORK, June 27 (Reuters) - Two widely used diabetes medicines, Januvia and Byetta, pose no additional risk for cases of inflamed pancreas compared with other diabetes drugs, according to an ...
BOSTON (Reuters) - Eli Lilly and Co and Amylin Pharmaceuticals Inc said on Tuesday that a trial of their diabetes drug Byetta, which was recently linked with six deaths from pancreatitis, reduced ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...
Resource4thePeople announced today that it providing consumers who are following the progress of lawsuits alleging that a class of diabetes medications including Januvia, Janumet, Byetta and Victoza ...
The Food and Drug Administration said on Friday that there may be a connection between Merck & Co.'s diabetes treatment Januvia and occurrences of acute pancreatitis, the same issue that sunk sales of ...
If you have had pancreatitis inflammation of the pancreas, it is not known if you have a higher chance of getting it while taking JANUVIA. Before you start taking JANUVIA, tell your doctor if you have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback